Fig. 1From: Clinical application of the AUC-guided dosage adjustment of docetaxel-based chemotherapy for patients with solid tumours: a single centre, prospective and randomised control studyComparison of the key PK parameters of AUC of each treatment cycle between BSA and PK groups. From the third treatment cycle, the AUC of paclitaxel in the PK group was significantly lower than that in the BSA groupBack to article page